KPV, the C-terminal tripeptide of -MSH, inhibits NF-B and MAP-kinase inflammatory signaling at nanomolar concentrations, reducing pro-inflammatory cytokine output adding an anti-inflammatory axis to the blend's repair-focused components
The FDA-approved label is specific: administer it "on an empty stomach, one-half to one hour before breakfast with a full glass of water" (MedlinePlus levothyroxine information)
Sources Fralin Biomedical Research Institute at VTC, news release, Oct
For High Oxidative Stress or Detox Support Individuals dealing with heavy pollution exposure, smoking history, chronic stress, or metabolic imbalance may require higher support, typically 1,0002,000 mg per day (NIH)